Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q2 2018 · 10-Q
Revenue$575.91M$575.91M+14.1% vs Q2 2017 Net Income$268.00M$268.00M+5,260.0% vs Q2 2017 EPS Diluted$8.87$8.87+5,117.6% vs Q2 2017 Gross Profit$301,700,000+10.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$77,862,000+24.6% Free Cash Flowderived$51,149,000+38.7% Margins · derivedGross margin52.4%−1.8 pt vs Q2 2017
Operating margin7.6%+7.9 pt vs Q2 2017
Net margin46.5%+45.5 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 9, 2018 · 40 d after period end